Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone Block of Low-dose Ketamine
NCT00921765Phase 4Terminated
- Sponsor
- Ullevål University Hospital
- Start
- Dec 2009
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketamine in pain (4 arms), sponsored by Ullevål University Hospital. Primary endpoint: Pain intensity (Numerical Rating Scale) at 30 minutes. Started Dec 2009; status: terminated.
02
Drugs
ketamine
03
Conditions
pain
Beyond the preview
Go deeper on NCT00921765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00921765.